Related Experiment Videos
Multiple myeloma in the geriatric patient
Cancer
|September 1, 1990
Summary
Older patients with multiple myeloma (a blood cancer) have significantly poorer survival rates. Age and hemoglobin levels are key prognostic factors, highlighting the need for tailored geriatric care.
Area of Science:
- Hematology
- Geriatric Medicine
- Oncology
Background:
- Multiple myeloma is a cancer of plasma cells.
- Optimal treatment strategies for elderly patients remain unclear.
Purpose of the Study:
- To compare the clinical characteristics and survival of elderly (≥75 years) and younger (<75 years) multiple myeloma patients.
- To identify significant prognostic factors for survival in multiple myeloma.
Main Methods:
- Retrospective analysis of consecutive multiple myeloma patients.
- Comparison of survival outcomes between age groups (≥75 vs <75).
- Multivariate analysis to identify predictors of survival.
Main Results:
- Patients aged 75 and older had significantly higher mortality within 12 months (82%) compared to younger patients (26%) (P<0.001).
- Age and hemoglobin levels were significant predictors of survival (P<0.012 and P<0.002, respectively).
- Bone lesions, bone marrow plasma cell percentage, serum monoclonal protein, functional class, and Salmon and Durie staging did not significantly impact survival in multivariate analysis.
Conclusions:
- Age and hemoglobin levels are the most critical prognostic indicators in multiple myeloma.
- Geriatric patients with multiple myeloma require distinct therapeutic approaches, including specialized chemotherapy and geriatric assessment with supportive care.